Table 2 Surgical outcomes of patients in the ICIC and CUS groups in the matched cohort

Overall operative time, min, median (IQR)

463 (440–530)

288 (256–360)

<0.001

Radical cystectomy time, min, median (IQR)

180 (146–200)

164 (136–205)

0.731

Estimated blood loss, ml, median (IQR)

392 (194–537)

150 (106–275)

0.011

Transfusion, n (%)

9

(36.0)

4

(16.0)

0.196

Pathological tumor stage < 2, n (%)

10

(40.0)

9

(36.0)

1.000

Pathological tumor stage ≥ 2, n (%)

15

(60.0)

16

(64.0)

Lymph node yield, median (IQR)

15 (8–21)

13 (7–18)

0.426

Positive lymph node, n (%)

7

(28.0)

3

(12.0)

0.289

Time to liquid, POD, median (IQR)

2 (1–3)

1 (1–1)

<0.001

Time to meal, POD, median (IQR)

4 (3–5)

2 (2–2)

<0.001

Time to flatus, POD, median (IQR)

2 (2–3)

1 (1–2)

0.001

Time to bowel, POD, median (IQR)

3 (3–5)

4 (3–5)

0.437

Hospital stay, days, median (IQR)

26 (20–35)

21 (16–29)

0.093

30-d Complication

12

(48.0)

10

(40.0)

0.776

Minor complication, n (%)

6

(24.0)

5

(20.0)

1.000

Major complication, n (%)

6

(24.0)

5

(20.0)

1.000

30-d Readmission, n (%)

1

(4.0)

1

(4.0)

1.000

30-d Reoperation, n (%)

1

(4.0)

0

(0.0)

1.000

90-d Complication

4

(16.0)

7

(28.0)

0.496

Minor complication, n (%)

3

(12.0)

4

(16.0)

1.000

Major complication, n (%)

1

(4.0)

3

(12.0)

0.609

90-d Readmission, n (%)

2

(8.0)

6

(24.0)

0.247

90-d Reoperation, n (%)

1

(4.0)

0

(0.0)

1.000

Stent free, n (%)

25

(100.0)

3

(12.0)

<0.001